STATEMENT OF THE PROBLEM
Over the past several decades, the scope of practice for emergency medical personnel has rapidly expanded.1 Along with this, a dramatic increase in the number of prehospital procedures (especially intubation and central venous access) has been noted.2,3 However, this dramatic change in the prehospital approach to the injured patient has occurred in the absence of data to support its adoption. Investigators from Los Angeles have noted no difference in survival when injured patients are transported by a private vehicle or emergency medical services (EMS) transport.4,5 Liberman et al.6 recently evaluated Canadian cities with Level I trauma centers and demonstrated no difference in outcomes between the basic life support delivered by EMS providers and the prehospital advanced life support delivered by either paramedics or physicians.
Despite a lack of evidence demonstrating a benefit to prehospital fluid resuscitation, this practice is considered to be standard of care. As well, the type of fluid, the appropriate rate of administration, and the resuscitations themselves remain unguided and unsupervised. Recently, the largest prehospital organization in the United Kingdom issued a consensus statement calling for more “restrained” and “cautious” use of crystalloids in prehospital settings.7 The authors argue that several prehospital hemorrhage models have demonstrated that limiting the initial resuscitation volume, before definitive care, leads to a reduction in hemorrhage.8,9 Unfortunately, clinical extrapolation of deliberate hypotension has, for the most part, been confined to a single prospective trial by Bickell et al.10 The investigators noted a decreased length of stay and lower mortality in patients with delayed resuscitation.
Although the need and benefit of prehospital interventions has been controversial for quite some time, an increasing amount of evidence has stirred both sides into more frequent debate. Proponents of the traditional “scoop-and-run” technique argue that this approach allows a more timely transfer to definitive care facilities and limits unnecessary (and potentially harmful) procedures. However, advocates of the “stay-and-play” method point to improvement in survival to reach the hospital and better neurologic outcomes after brain injury. Given the lack of consensus, the Eastern Association for the Surgery of Trauma convened a Practice Management Guideline (PMG) committee to answer the following questions regarding prehospital resuscitation (1): should injured patients have vascular access attempted in the prehospital setting? (2) if so, what location is preferred for access? (3) if access is achieved, should intravenous fluids be administered? (4) if fluids are to be administered, which solution is preferred? and (5) if fluids are to be administered, what volume and rate should be infused?
Identification of References
A primary computerized search of the National Library of Medicine and the National Institute of Health MEDLINE database was undertaken using the PubMed Entrez interface. This search was undertaken by a Masters of Library Sciences Faculty member at Vanderbilt University School of Medicine. All English language citations between 1982 and 2007 focusing on prehospital vascular access and fluid resuscitation of trauma patients were reviewed. This primary search query retrieved 3,300 citations:
- fluid AND prehospital, OR out of hospital, OR field, AND resuscitation, AND injury
- access OR vascular OR intravenous OR cannulation AND prehospital OR field OR out of hospital AND injury
- prehospital AND injury AND dextrans/ or Sodium Chloride/ or Saline Solution, Hypertonic/ or saline OR blood substitute OR fluids
- intraosseous AND access
Review articles, letters to the editor, case reports, and editorials were excluded. Basic science and animal studies, as well as items limited to pediatric patients and noninjured patients were also excluded. Excluding studies with the above-stated populations limited this literature query to 79 articles.
A secondary query was carried out by PMG study group members (BAC, BRC) using the OVID database version of MEDLINE with the same search terms, exclusion, and date range. The secondary search criteria yielded 92 citations after above-stated exclusions.
There were 12 citations that were missed on the primary that were detected on the secondary. Searches merged and the removal of articles that did not strictly apply to the study questions and population of interest yielded 58 articles. A total of 16 articles were reviewed by the committee and determined by the members to be technical studies (flow rates for catheters and/or delivery systems) or mixed populations of patients (medical and surgical not purely trauma). Exclusion of these left 42 total articles that formed our evidence-based review and populated Tables 1–5.
Quality of the References
The references were classified using methodology established by the Agency for Health Care Policy and Research of the U.S. Department of Health and Human Services (add reference).11 Additional criteria and specifications were used for classification of articles from a tool described by Oxman et al.12 Thus, the classifications were as follows:
- Class I: Prospective, randomized controlled trials. A total of 10 Class I articles were reviewed.
- Class II: Clinical studies prospectively collected data and retrospective analyses, which were based on clearly reliable data. Fourteen articles met criteria for Class II articles and were reviewed.
- Class III: Studies based on retrospectively collected data; includes clinical series, database or registry reviews, large series of case reviews, and expert opinion. Eighteen articles were identified as class III and underwent review. Each of the above articles was reviewed and scored by a minimum of two PMG committee members. After collection of all reviews, the prehospital Fluid Resuscitation PMG Committee convened and developed recommendations based on the following definitions:
- Level I: The recommendation is convincingly justifiable based on the available scientific information alone. One Level I guideline was supported by the literature.
- Level II: The recommendation is reasonably justifiable by available scientific evidence and strongly supported by expert opinion. A total of eight Level II guidelines were established by the literature.
- Level III: The recommendation is supported by available data but adequate scientific evidence is lacking. Seven Level III guidelines were developed.
Should vascular access be obtained in the prehospital setting? (Table 1).7,13–28
- Level I: No level one recommendation can be made. There is insufficient data to support a Level I recommendation for placing vascular access in the prehospital setting.
- Level II: Placement of vascular access at the scene of injury should not be performed as it delays patient transport to definitive care, and there is no evidence to demonstrate any benefit to their placement.
- Level III: Placement of vascular access during transport is feasible and does not delay transport to definitive care.
If vascular access is obtained, where and how should it be placed? (Table 2).7,10,27,29–43
- Level I: No Level I recommendation can be made. There is insufficient data to support specifically where and through which approach vascular access should be obtained in the prehospital setting of trauma.
- Level II: (a) If central access is necessary, the percutaneous “Seldinger” technique is recommended over traditional “cut-down” procedures as there is evidence that percutaneous techniques are quicker and have equivalent success rates. (b) The use of intraosseous access in trauma patients requiring vascular access in which intravenous access is unobtainable or has failed two attempts is recommended.
- Level III: Attempts at peripheral intravenous access should be limited to two attempts during prehospital transport after which, alternative methods (intraosseous, central access) should be attempted if equipment and trained personnel are available.
If vascular access is obtained, should intravenous fluids be given? (Table 3).7,10,27,30–34,38–42
- Level I: No level one recommendation can be made. There is insufficient data to show that trauma patients benefit from prehospital fluid resuscitation.
- Level II: (a) Intravenous fluids should be withheld in the prehospital setting in patients with penetrating torso injuries. (b) An IV placed to “saline-lock” is equivalent in patency and function to a continuous infusion.
- Level III: (a) Intravenous fluid resuscitation should be withheld until active bleeding/hemorrhage is addressed. (b) Intravenous fluid administration in the prehospital setting (regardless of mechanism or transport time) should be titrated for palpable radial pulse using small boluses of fluid (250 mL) rather than fixed volumes or continuous administration.
If fluid is given, which type of fluid should be chosen? (Table 4).44–52
- Level I: (a) There is insufficient data to recommend one solution or type of fluid over other options in the prehospital setting. (b) Small volume boluses (250 mL) of 3% and 7.5% hypertonic saline (HTS) are equivalent, with respect to vascular expansion and hemodynamic changes, to large volume boluses (1 L) of standard solutions such as lactated Ringer’s (LR) or 0.9% normal saline (NS).
- Level II: There is insufficient data to support any recommendation at this level.
- Level III: There administration of blood in the prehospital setting is safe and feasible.
If fluid is given, how much and how fast should it be administered? (Table 5).10,39,42,50,51
- Level I: No level one recommendation can be made. There is insufficient data to recommend specific rates or volumes of fluids to be administered in the prehospital setting.
- Level II: Fluids run at “keep vein open” rates are adequate for transporting injured patients.
- Level III: Rapid infusion systems and/or pressurized systems (to deliver fluids more rapidly) should not be used in the prehospital setting.
On the heels of an ever expanding Prehospital Trauma Life Support curriculum, we have seen not only an expansion in the procedural skills set of EMS providers, but also a dramatic increase in the number of procedures performed. Although there is evidence to suggest potential benefit of prehospital procedures in rural blunt trauma patients with prolonged transportation time, there is little (if any) data to justify these procedures in patients with penetrating injuries or those with short transport times (less than 30 minutes).10,27,53 Advanced Trauma Life Support guidelines for administering (up to 2 L) crystalloid to hypotensive trauma patients in the emergency room setting have been adopted into the prehospital environment without clear benefit. In addition, recent data has shown that the performance of prehospital procedures in urban and penetrating settings have a negative impact on survival.25 In light of the expanding data calling into to question the “stay and play” method of prehospital care, the EAST PMG committee conducted a review of the currently available literature on prehospital vascular access and fluid resuscitation.
Should Vascular Access Be Obtained in the Prehospital Setting?
The first issue examined was whether or not vascular access should even be attempted in the prehospital setting. Several investigators have evaluated the success rate for prehospital venous access and noted scene placement times of these lines range from a mean of 2.2 minutes to 6.3 minutes.18–20,23,27 “Time to placement” of these lines was similar in patients with normal blood pressure and primary injuries confined to the extremities.13,15,22 However, when patients were hypotensive or had primarily torso injuries, placement at the scene tended to be longer than that of en route intravenous line placement.21,26,27 Jones et al.19 noted a 91% success rate at the scene and a 94% success rate en route. Additionally, Slovis et al.26 demonstrated an en route success rate for intravenous line placement of 92%, regardless of hemodynamic status. Delaying transport to place venous access also seems to be associated with increased overall time to hospital, in some cases exceeding that of the actual transport itself.24,25,27 Should the decision be made to obtain scene access, drawing blood for laboratory samples (e.g., type and screen, etc) adds unnecessary time and should not be performed.23
Whether the committee felt it was able to recommend placement of access in the prehospital setting was predicated on demonstrating any benefit from access placement. Although several studies evaluating prehospital venous access have recommended their placement (simply because they could technically be placed), none of the investigators was able to demonstrate any benefit from their placement.18,20,23 To the contrary, scene access placement has been associated with increased risk of death.14,24,27 Seamon et al.25 evaluated 180 patients who underwent ED thoracotomy over a 6-year period. The authors stratified according to method of transport (EMS or private vehicle/police [POV]). They found that mortality in patients arriving by EMS was double that of patients transported by POV (17% vs. 8.0%). More importantly, each prehospital procedure performed reduced the odds of survival by 62% (OR, 0.38; 95% CI, 0.18–0.79; p = 0.009). Sampalis et al.25 examined the association between on-site venous access and fluid replacement and mortality in critically injured patients. The authors found that on-site access was associated with an increase in mortality (23% IV group vs. 6% no IV group) and that this association was stronger as time to hospital arrival increased (OR, 8.4; CI, 1.27–54.69; p = 0.03 for time to arrival >60 minutes). These outcomes (as well as time to placement of access and scene times) do not seem to differ whether the patient is transported by basic life support (BLS) or advanced life support ambulance crews.
In light of increasing experience in management of military injuries (both penetrating and blunt), a UK consensus group was recently convened to reconcile differences in practice with respect to prehospital fluid resuscitation.7 The expert panel formulated an algorithm to assist in the early resuscitation of critically injured patients that consisted of the following: (1) access should not be obtained for superficial wounds, (2) if the patient’s mental status is appropriate and a radial pulse is present, prehospital personnel may place venous access but fluids should be held, (3) venous access should be obtained and fluids initiated if no radial pulse or mental status is incoherent, (4) a 500 mL bolus of hetastarch should be given if no radial pulse or mental status is incoherent, (5) fluids should be discontinued if pulse and mental status return, and (6) if no response, repeat 500 mL of colloid (hetastarch).7
If Access Is Obtained, Where Should It Be Placed?
In asking where to place venous access, it is important not only to determine where anatomically should this access be obtained, but also what approach should be used (percutaneous, cut-down) and what size catheter should be placed. As well, it is critical to evaluate whether there are alternatives to traditional intravenous catheter access (intraosseous lines). No clinical trials were found to suggest superiority of one anatomic location for venous access versus another. Peripheral access has been the standard location for placement in the prehospital setting; most commonly being placed in the upper extremity in the forearm and antecubital area. An animal study by Rosa et al. examined the efficacy of intravenous access site on delivery of a bolus injection to the heart during shock and resuscitation.54 The authors noted that femoral access significantly prolongs bolus transit time when compared with central or brachial access regardless of intravascular status (euvolemic, hypovolemic, or aggressively resuscitated). Brachial access was advocated as the preferred route for bolus injection delivery in the emergency setting as it provides expedient bolus delivery equal to central access and is superior to femoral access.
A few authors have evaluated the time-to-placement and efficiency of traditional peripheral access, cut-down placement, and percutaneous (Seldinger) approaches in the prehospital setting.29,36,43 Westfall et al.43 conducted a prospective, randomized, multicentered trial to compare the speed of IV access and the rate of infusion for saphenous vein cut-down and percutaneous femoral catheterization. Seventy-eight trauma patients were randomized to either saphenous cut-down or percutaneous femoral line placement, followed by passive infusion of 1.0 L of crystalloid. Mean procedure time for the cut-down group was 5.6 minutes ± 2.6 minutes compared with 3.2 minutes ± 1.2 minutes for the femoral line group (p < 0.001). The mean infusion time for the cut-down group was 6.6 minutes ± 4.3 minutes compared with 4.6 minutes ± 2.5 minutes for the femoral line group (p = 0.03). As the rate of flow increases with larger diameter and shorter length of the catheter (Poiseuille’s law), several investigators have examined the impact of placing larger bore lines in the prehospital setting. Benumof et al.29 measured the infusion pressure-flow characteristics of the side ports of 8.0 and 8.5 Fr introducer catheters against equivalent pressure-flow relationship through standard 22- to 14-gauge peripheral venous catheters. Although the 8.5 Fr introducers were superior to the 8.0 Fr catheters, none was superior to 14- and 16-gauge standard peripherally placed catheters. Other authors evaluated the ability to place extremely large bore peripheral lines (10- and 12-gauge catheters) and to rapidly exchange smaller peripheral lines out to large introducer catheters (over a wire).36,37 However, none demonstrated superiority to standard large bore (14–18 gauge) peripheral lines.
Over the last several years, intraosseous lines have been met with increasing enthusiasm and favor in the prehospital resuscitation of trauma patients. However, this enthusiasm is based on increasing provider “experiences” and not on any clinical trials. These studies are, for the most part, are limited to “how I do it” or device comparisons, using historical flow rates of intravenous catheters as reference values.55 Others are pharmacokinetic drug studies or trials conducted in nontrauma patients. Frascone et al.35 studied provider performance for obtaining intraosseous access with two FDA-approved intraosseous devices in two sequential field trials. They evaluated 178 insertions in adult trauma patients, with success rates of 72% to 87%. Time to insertion was similar to that of historical data on intravenous access. The site most often used for adult intraosseous access is the proximal tibia (medial and inferior to the tibial tuberosity) and the sternum and humeral head.55 Although the pharmacokinetic delivery of drugs seems equal to that of the intravenous route, infusion volume rates are only that of a 21-gauge catheter in the absence of a high-pressure infusion system.55,56
If Access Is Obtained, Should Fluid Be Administered in the Prehospital Setting?
Once access is established, another controversy arises in whether or not to initiate fluid therapy.34 Although many providers see the subsequent administration of fluids to be standard of care, the literature would not support this approach. At a minimum, prehospital fluid administration does not seem to improve outcomes in either penetrating or blunt trauma patients.27,32,39 In a study of 235 trauma patients (blunt and penetrating), Dalton32 evaluated the benefit of prehospital venous access and fluid administration. The authors noted that 80% patients receive less than 600 mL of fluid in the prehospital setting, regardless of mechanism, scene entrapment, or hypotension en route. They were unable to identify benefit from such therapy and recommended withholding fluid administration. Kaweski et al.39 conducted a retrospective study of almost 7,000 trauma patients and noted that mortality rates were similar in those patients who received fluids and those who did not (23% vs. 22%; p = NS). Comparison of groups with similar, injury severity, probability of survival, and hypotension on arrival also failed to show an influence of fluid administration on survival. Other authors have also demonstrated that prehospital fluid therapy confers no survival benefit and delays transport of critically injured patients.33,41
Although numerous animal studies have demonstrated an increased rate of hemorrhage an increased mortality with “prehospital” fluid resuscitation, clinical extrapolation of this concept has, for the most part, been confined to a single prospective randomized controlled trial by Bickell et al.10 in the early 1990s. Hypotensive patients with penetrating torso injuries were randomized in the field to receive either standard intravenous fluid resuscitation or no fluids, and the regimen was continued until the patient reached the operating theater. Despite the lack of prehospital fluid resuscitation, the mean blood pressure between the groups was similar while intraoperative blood loss was significantly less in the delayed resuscitation group. Additionally, the length of stay was shorter and the mortality rate lower in the delayed resuscitation group. Another randomized controlled trial by Turner et al.42 in the UK involved 1,309 patients, half of which were randomized to standard fluid protocols or no prehospital fluids. Unfortunately, not much can be derived from this study to make any recommendations, as there was extremely poor protocol compliance. Only 31% of standard protocol patients (who were supposed to receive fluids) received prehospital fluids and only 80% of the “no fluid” patients had fluids withheld. There was no significant difference in mortality between the groups. Despite the studies significant limitations, the authors concluded that prehospital fluid resuscitation does no harm.
Several groups and authors have developed consensus statements aimed directly at the question of whether to place venous access in the prehospital setting and whether to administer fluids before hospital arrival (and definitive hemorrhage control).7,37,55
In summary, the consensus recommendations are quite similar: (1) patients with only superficial wounds (even in combat settings) do not require immediate intravenous access or fluid resuscitation, (2) if the patient is coherent and has a palpable radial pulse, place the venous access to “saline lock,” (3) if incoherent or no radial pulse, obtain venous access and start 500 mL hetastarch, (4) repeat bolus if no response, saline lock IV if response noted, (5) in patients with suspected head injuries, fluids should be titrated for SBP >90 mm Hg. These recommendations reflect that of the groups’ evaluations of blunt and penetrating patients in both military and civilian settings.40
With respect to maintaining venous access patency, several authors have evaluated whether continuous intravenous infusion is necessary.30,31 Boyle and Kuntz30 evaluated 100 patients requiring intravenous access placement. The use of a saline lock was found to be a cost-effective means of maintaining patency of intravenous lines during transport. Carducci and Stein31 demonstrated that a saline lock device was as effective at maintaining prehospital access as were traditional continuous infusions. Additionally, paramedics found that the saline lock devices were easier to use, less time-consuming to initiate, and facilitated patient transportation.
If Fluid Is Administered, Which Solution Should Be Given?
Although “standard” fluid on prehospital vehicles is typically normal saline (0.9% sodium chloride NS) or lactated Ringer’s (LR) solution, neither has been well studied in the prehospital resuscitation of trauma and neither has been shown to be superior to other available solutions. However, their cost and provider familiarity with these solutions has likely been responsible for their “standard solution” status. Studies comparing various iso-oncotic solutions (hetastarch, dextran) and hypertonic saline (3% or 7.5% sodium chloride) to NS or LR have shown mixed results.46,47,50,52,57–61
Cooper et al.45 recently compared LR and 7.5% sodium chloride in a randomized trial of trauma patients with either brain injury or hypotension. The authors found no significant difference between the groups with respect to favorable neurologic outcomes at 6 months. Survival to discharge and 6-month survival were higher in the 7.5% sodium chloride group (55% vs. 50% and 55% vs. 47%, respectively), but this did not reach statistical significance (study powered to detect difference in neurologic outcomes). In a trial of patients undergoing air medical transport after injury, Vassar et al.51,52 compared 7.5% sodium chloride (with and without dextran) with LR solution in a randomized fashion. The authors found that patients who received the hypertonic saline solutions had less fluid requirements in the prehospital setting and arrived to the trauma center with a higher systolic blood pressure. Although overall survival was not different between the hypertonic saline and LR groups, patients with severe head injury who received hypertonic saline had a higher survival than that observed with the LR groups (32% vs. 16%; p = 0.044). The same group evaluated 0.9% sodium chloride (NS) with several hypertonic saline solutions in hypotensive patients transported by ground ambulance.52 In this randomized, controlled and prehospital blinded trial, the authors found no difference in survival between patients who received 0.9% or 7.5% sodium chloride. However, the groups were poorly matched with significantly higher injury severity scores and predicted mortality in the 7.5% groups compared with the 0.9% group (both p < 0.05). In addition, the study was severely underpowered with an estimated sample size calculation required of almost 700 patients (study had 258 patients).
Numerous investigators have examined the different hypertonic solutions available, including 3% and 7.5% sodium chloride and solutions with and without added colloids (6% and 12% dextran).45–47,50–52,57–59,62–64 With respect to 3% versus 7.5% sodium chloride, there are few, if any, animal studies comparing the solutions and no clinical trials of prehospital resuscitation of trauma. In a porcine model of uncontrolled hemorrhage, Watters et al.64 recently evaluated the effect of 3% versus 7.5% sodium chloride. The authors noted that a single bolus of 3% solution produced an adequate and sustained rise in blood pressure and tissue oxygenation, whereas 7.5% sodium chloride failed to produce a sustained improvement in these variables. Also, the 7.5% sodium chloride solution resulted in a significant dilutional anemia and relative hypofibrinogenemia. Prehospital clinical trials have utilized 7.5% sodium chloride (with and without dextran) almost exclusively, thus preventing a critical comparison of and evidenced-based recommendation by the committee for one over the other.46–48,50–52,58 As to the benefit of adding colloid to hypertonic saline, solutions of 7.5% sodium chloride with 6% or 15% dextran added do not seem superior to those without dextran.50–52 Vassar et al.50 noted that the use of 7.5% sodium chloride was superior to LR in reducing the amount of prehospital fluid requirements and improving admission/emergency department blood pressure, with no additional benefit seen with the dextran solutions. Glasgow outcome scores were higher in the 7.5% group compared with lactated Ringer’s, but no further effect was observed with the dextran solutions.
Hydroxylethylstarch (HES) is a balanced electrolyte solution that is similar in ionic composition to human plasma.65,66 Although it is contraindicated in patients with bleeding disorders, HES is used and advocated by the military for prehospital, low-volume boluses of injured soldier’s in hemorrhagic shock.38,40 In fact, several near-fatal hemorrhage models have demonstrated that HES is associated with hemorrhage volume and significantly lower mortality when compared with LR.47,61–63 Compared with normal saline and lactated Ringer’s solution, HES is associated with significant decreases in release of proinflammatory cytokines.19,62–64 When compared with LR, HES solutions in animals with trauma-hemorrhagic shock has been shown to induce less inflammatory cytokines and improved immune function.
Clinical trials evaluating blood and blood substitutes in the prehospital setting are also scarce and prevented the committee from making any significant recommendation on the subject. Barkana et al.44 evaluated 40 patients who had received prehospital blood transfusions. Prolonged extrication and delayed transport were the primary indications for transfusion and the mean volume of crystalloid infused by hospital arrival was almost 4.5 L. During the study period, only 4% of blood reserved for prehospital patients was actually used (vs. 90% during that period for in-hospital use). Although the authors found it safe and feasible to transfuse blood in the prehospital setting, there was a tremendous amount of product wastage. Sumida et al.49 performed a chart review of patients receiving prehospital resuscitation with blood products and found no difference in mortality. The authors noted that the crystalloid only group, however, had shorter transport times and more “normal” vital signs in the field. As to blood substitutes, data regarding use in trauma patients are extremely limited while that for prehospital resuscitation are essentially nonexistent.67,68 Gould et al.65 conducted a prospective, randomized, open label trial of a human polymerized hemoglobin substitute. Forty-four in-hospital trauma patients were randomized to receive red cells or up to six units of the blood substitute as their initial blood replacement after trauma and during emergent operations. The total number of allogeneic red cell transfusions for the control and experimental groups was not significantly different through study day 3 (11.3 ± 4.1 units vs. 7.8 ± 4.2 units; p = 0.06).
If Fluid Is Administered, How Much Should Be Given and How Fast Should It Be Infused?
Even more poorly understood and more under-studied than the above controversies is that of “how much” and “how fast.” Basic trauma guidelines recommend an initial rapid infusion of fluid (1.0–2.0 L) in hypotensive trauma patients as a diagnostic procedure to aid treatment decisions. Although this has been interpreted (or misinterpreted) to mean that patients in the prehospital setting should receive 2.0 L of crystalloid (often regardless of hemodynamic status), this practice is not supported by the literature. Currently, there are no clinical trials to support a recommendation for rate or volume of fluid administration to trauma patients in the prehospital setting. Animal studies have been performed that suggest higher volumes and more rapid infusions of crystalloid in the prehospital setting result in higher mortality.63,64,66,69–71 Using a murine model of uncontrolled hemorrhage, Krausz et al.72 compared bolus and continuous infusion administration of lactated Ringer’s and hypertonic saline, combined with splenectomy. Continuous infusion of LR solution resulted in significantly less bleeding than bolus infusion and improved survival time, whereas there was no difference in continuous or bolus infusion of hypertonic saline. Bickell et al.10 demonstrated that patients with penetrating torso injury who received small volumes of resuscitation (<250 mL) in the prehospital setting had significantly higher survival to hospital discharge than those who received standard prehospital resuscitation (750—1,000 mL in less than 30 minutes). Vassar et al.50–52 noted that hypertonic saline boluses (on the order of 250 mL volumes) seem to be associated with improved survival.
In-patient clinical trials suggest that “lowering expectations” of resuscitation end-points may improve survival and decrease hemorrhage volume. Dutton et al.9 evaluated the concept of “hypotensive resuscitation” and noted that titration of initial fluid therapy to a lower than normal systolic blood pressure (SBP) (≥70 mm Hg instead of >100 mm Hg) during active hemorrhage did not affect mortality. Several years earlier, this same group of investigators evaluated the delivery of crystalloid and blood products through a rapid infusion system to critically injured patients in hemorrhagic shock.73 Contrary to beliefs and biases at the time, the investigators noted an almost fivefold increase in mortality in patients resuscitated with a rapid infusion system. This higher mortality remained even after matching for age, injury severity scores, and Glasgow coma scale (53% vs. 61%; p < 0.001). Even more surprising was that the mortality difference was greatest not in penetrating patients but in the blunt trauma population (48.8% vs. 63.0%; p < 0.001).
Despite the widely held belief that prehospital venous access placement and fluid resuscitation is standard of care, there is little data to support this practice. In fact, an increasing amount of data suggests that it may be quite harmful to a significant number of critically injured patients. The EAST PMG committee has found that placement of venous access at the scene delays transport and placement of access en route should be considered. In those patients in whom intravenous access has failed, intraosseous may be attempted if equipment and trained personnel are available. There is insufficient data to suggest that blunt or penetrating trauma patients benefit from prehospital fluid resuscitation. In patients with penetrating injuries and short transport times (less than 30 minutes), fluids should be withheld in the prehospital setting in patients who are alert or have a palpable radial pulse. Fluids (in the form of small boluses, i.e., 250 mL) should be given to return the patient to a coherent mental status or palpable radial pulse. In the setting of traumatic brain injury, however, fluids should be titrated to maintain systolic blood pressure greater than 90 mm Hg (or mean pressure greater than 60 mm Hg). Hypertonic saline boluses of 250 mL seem equivalent in efficacy to 1,000 mL boluses of standard solutions (lactated Ringer’s, 0.9% sodium chloride). There is insufficient evidence to show that injured patients with short transport times benefit from prehospital blood transfusions. Finally, rapid infusion systems and or pressurized devices (to deliver fluids more rapidly) should not be used in the prehospital setting.
1. Salomone JP, Ustin JS, McSwain NE Jr, Feliciano DV. Opinions of trauma practitioners regarding prehospital interventions for critically injured patients. J Trauma
2. Bochicchio GV, Ilahi O, Joshi M, Bochicchio K, Scalea TM. Endotracheal intubation in the field
does not improve outcome in trauma patients who present without an acutely lethal traumatic brain injury. J Trauma
3. Wang HE, Peitzman AB, Cassidy LD, Adelson PD, Yealy DM. Out-of-hospital endotracheal intubation and outcome after traumatic brain injury. Ann Emerg Med
4. Cornwell EE III, Belzberg H, Hennigan K, et al. Emergency medical services (EMS) vs non-EMS transport of critically injured patients: a prospective evaluation. Arch Surg
5. Demetriades D, Chan L, Cornwell E, et al. Paramedic vs. private transportation of trauma patients. Effect on outcome. Arch Surg
6. Liberman M, Mulder D, Lavoie A, Denis R, Sampalis JS; Multicenter Canadian study of prehospital trauma care. Ann Surg
7. Fluid resuscitation in pre-hospital trauma care: a consensus view. J R Army Med Corps
8. Dretzke J, Sandercock J, Bayliss S, Burls A. Clinical effectiveness and cost-effectiveness of prehospital intravenous fluids in trauma patients. Health Technol Assess
9. Dutton RP, Mackenzie CF, Scalea TM. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma
10. Bickell WH, Wall MJ Jr, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med
11. Oxman AD, Cook DJ, Guyatt GH. Users’ guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. JAMA
12. Oxman AD, Schunemann HJ, Fretheim A. Improving the use of research evidence in guideline development. XIV. Reporting guidelines. Health Res Policy Syst
13. Barrett B, Guly HR. How long does it take to perform procedures on scene? Prehospital Immed Care
14. Cayten CG, Murphy JG, Stahl WM. Basic life support versus advanced life support for injured patients with an injury severity score of 10 or more. J Trauma
15. Gausche M, Tadeo RE, Zane MC, Lewis RJ. Out-of-hospital intravenous access: unnecessary procedures and excessive cost. Acad Emerg Med
16. Hedges JR, Feero S, Moore B, Shultz B, Haver DW. Factors contributing to paramedic onscene time during evaluation and management of blunt trauma. Am J Emerg Med
17. Henderson RA, Thomson DP, Bahrs BA, Norman MP. Unnecessary intravenous access in the emergency setting. Prehosp Emerg Care
18. Honigman B, Rohweder K, Moore EE, Lowenstein SR, Pons PT. Prehospital advanced trauma life support for penetrating cardiac wounds. Ann Emerg Med
19. Jones SE, Nesper TP, Alcouloumre E. Prehospital intravenous line placement: a prospective study. Ann Emerg Med
20. Minville V, Pianezza A, Asehnoune K, Cabardis S, Smail N. Prehospital intravenous line placement assessment in the French emergency system: a prospective study. Eur J Anaesthesiol
21. O’Gorman M, Trabulsy P, Pilcher DB. Zero-time prehospital i.v. J Trauma
22. Pace SA, Fuller FP, Dahlgren TJ. Paramedic decisions with placement of out-of-hospital intravenous lines. Am J Emerg Med
23. Pons PT, Moore EE, Cusick JM, Brunko M, Antuna B, Owens L. Prehospital venous access in an urban paramedic system—a prospective on-scene analysis. J Trauma
24. Sampalis JS, Tamim H, Denis R, et al. Ineffectiveness of on-site intravenous lines: is prehospital time the culprit? J Trauma
25. Seamon MJ, Fisher CA, Gaughan J, et al. Prehospital procedures before emergency department thoracotomy: “scoop and run” saves lives. J Trauma
26. Slovis CM, Herr EW, Londorf D, Little TD, Alexander BR, Guthmann RJ. Success rates for initiation of intravenous therapy en route by prehospital care providers. Am J Emerg Med
27. Smith JP, Bodai BI, Hill AS, Frey CF. Prehospital stabilization of critically injured patients: a failed concept. J Trauma
28. Spaite DW, Tse DJ, Valenzuela TD, et al. The impact of injury severity and prehospital procedures on scene time in victims of major trauma. Ann Emerg Med
29. Benumof JL, Wyte SR, Rogers SN. A large catheter sheath introducer with an increased side-port functional gauge. Crit Care Med
30. Boyle MF, Kuntz B. Saline locks in prehospital care. Prehosp Disaster Med
31. Carducci B, Stein K. Intravenous maintenance with a saline lock intermittent infusion device in the prehospital environment. Prehosp Disaster Med
32. Dalton AM. Prehospital intravenous fluid replacement in trauma: an outmoded concept? J R Soc Med
33. Dula DJ, Wood GC, Rejmer AR, Starr M, Leicht M. Use of prehospital fluids in hypotensive blunt trauma patients. Prehosp Emerg Care
34. Eckstein M, Chan L, Schneir A, Palmer R. Effect of prehospital advanced life support on outcomes of major trauma patients. J Trauma
35. Frascone RJ, Jensen JP, Kaye K, Salzman JG. Consecutive field
trials using two different intraosseous devices. Prehosp Emerg Care
36. Guisto JA, Iserson KV. The feasibility of 12-gauge intravenous catheter use in the prehospital setting. J Emerg Med
37. Herron H, Falcone R, Dean B, et al. 8.5 French peripheral intravenous access during air medical transport of the injured patient. Air Med J
38. Holcomb JB. Fluid resuscitation in modern combat casualty care: lessons learned from Somalia. J Trauma
39. Kaweski SM, Sise MJ, Virgilio RW. The effect of prehospital fluids on survival in trauma patients. J Trauma
40. Revell M, Porter K, Greaves I. Fluid resuscitation in prehospital trauma care: a consensus view. Emerg Med J
41. Talving P, Palstedt J, Riddez L. Prehospital management and fluid resuscitation in hypotensive trauma patients admitted to Karolinska University Hospital in Stockholm. Prehosp Disaster Med
42. Turner J, Nicholl J, Webber L, Cox H, Dixon S, Yates D. A randomised controlled trial of prehospital intravenous fluid replacement therapy in serious trauma. Health Technol Assess
43. Westfall MD, Price KR, Lambert M, et al. Intravenous access in the critically ill trauma patient: a multicentered, prospective, randomized trial of saphenous cutdown and percutaneous femoral access. Ann Emerg Med
44. Barkana Y, Stein M, Maor R, Lynn M, Eldad A. Prehospital blood transfusion in prolonged evacuation. J Trauma
45. Cooper DJ, Myles PS, McDermott FT, et al. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA
46. Holcroft JW, Vassar MJ, Turner JE, et al. 3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients. Ann Surg
47. Maningas PA, Mattox KL, Pepe PE, Jones RL, Feliciano DV, Burch JM. Hypertonic saline-dextran solutions for the prehospital management of traumatic hypotension. Am J Surg
48. Mattox KL, Maningas PA, Moore EE, et al. Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension. The U.S.A. Multicenter Trial. Ann Surg
49. Sumida MP, Quinn K, Lewis PL, et al. Prehospital blood transfusion versus crystalloid alone in the air medical transport of trauma patients. Air Med J
50. Vassar MJ, Fischer RP, O’Brien PE, et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Arch Surg
51. Vassar MJ, Perry CA, Gannaway WL, Holcroft JW. 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Arch Surg
52. Vassar MJ, Perry CA, Holcroft JW. Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. J Trauma
53. Branas CC, Sing RF, Davidson SJ. Urban trauma transport of assaulted patients using nonmedical personnel. Acad Emerg Med
54. Rosa DM, Griffin CC, Flanagan JJ Jr, Machiedo GW. A comparison of intravenous access sites for bolus injections during shock and resuscitation after emergency room thoracotomy with and without aortic crossclamping. Am Surg
55. Fowler R, Gallagher JV, Isaacs SM, Ossman E, Pepe P, Wayne M. The role of intraosseous vascular access in the out-of-hospital environment (resource document to NAEMSP position statement). Prehosp Emerg Care
56. Von Hoff DD, Kuhn JG, Burris HA III, Miller LJ. Does intraosseous equal intravenous? A pharmacokinetic study. Am J Emerg Med
57. Hashiguchi N, Lum L, Romeril E, et al. Hypertonic saline resuscitation: efficacy may require early treatment in severely injured patients. J Trauma
58. Holcroft JW, Vassar MJ, Perry CA, Gannaway WL, Kramer GC. Use of a 7.5% NaCl/6% Dextran 70 solution in the resuscitation of injured patients in the emergency room. Prog Clin Biol Res
59. Maningas PA. Resuscitation with 7.5% NaCl in 6% dextran-70 during hemorrhagic shock in swine: effects on organ blood flow. Crit Care Med
60. Vassar MJ, Perry CA, Holcroft JW. Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock. Arch Surg
61. Wade CE, Dubick MA, Vassar MJ, Perry CA, Holcroft JW. Plasma dextran concentrations in trauma patients administered hypertonic saline-dextran-70. Clin Chem
62. Pinto FC, Capone-Neto A, Prist R, E Silva MR, Poli-de-Figueiredo LF. Volume replacement with lactated Ringer’s or 3% hypertonic saline solution during combined experimental hemorrhagic shock and traumatic brain injury. J Trauma
63. Stern SA, Kowalenko T, Younger J, Wang X, Dronen SC. Comparison of the effects of bolus vs. slow infusion of 7.5% NaCl/6% dextran-70 in a model of near-lethal uncontrolled hemorrhage. Shock
64. Watters JM, Tieu BH, Differding JA, Muller PJ, Schreiber MA. A single bolus of 3% hypertonic saline with 6% dextran provides optimal initial resuscitation after uncontrolled hemorrhagic shock. J Trauma
65. Schmand JF, Ayala A, Morrison MH, Chaudry IH. Effects of hydroxyethyl starch after trauma-hemorrhagic shock: restoration of macrophage integrity and prevention of increased circulating interleukin-6 levels. Crit Care Med
66. Schmand JF, Ayala A, Chaudry IH. Effects of trauma, duration of hypotension, and resuscitation regimen on cellular immunity after hemorrhagic shock. Crit Care Med
67. Gould SA, Moore EE, Hoyt DB, et al. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg
68. Gould SA, Moore EE, Hoyt DB, et al. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J Am Coll Surg
69. Krausz MM, Bashenko Y, Hirsh M. Crystalloid and colloid resuscitation of uncontrolled hemorrhagic shock following massive splenic injury. Shock
70. Sumas ME, Legos JJ, Nathan D, Lamperti AA, Tuma RF, Young WF. Tonicity of resuscitative fluids influences outcome after spinal cord injury. Neurosurgery
71. Varicoda EY, Poli de Figueiredo LF, Cruz RJ Jr, Silva LE, Rocha e Silva M. Blood loss after fluid resuscitation with isotonic or hypertonic saline for the initial treatment of uncontrolled hemorrhage induced by spleen rupture. J Trauma
72. Krausz MM, Hirsh M. Bolus versus continuous fluid resuscitation and splenectomy for treatment of uncontrolled hemorrhagic shock after massive splenic injury. J Trauma
73. Hambly PR, Dutton RP. Excess mortality associated with the use of a rapid infusion system at a level 1 trauma center. Resuscitation